ANALYSIS OF KRAS MUTATIONS IN NON-SMALL CELL LUNG CANCER (NSCLC) BRAZILIAN PATIENTS

被引:0
|
作者
Couto, Patricia G. P. [1 ]
Bastos-rodrigues, Luciana [1 ]
Sabato, Cristina [1 ]
Guieiro, Fernanda [1 ]
Vilhena, Alyne [2 ]
Amaral, Nilson F. [2 ]
De Marco, Luiz [1 ]
机构
[1] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil
[2] Hosp Julia Kubitscheck, Belo Horizonte, MG, Brazil
关键词
INDELS; NSCLC; Kras;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S735 / S736
页数:2
相关论文
共 50 条
  • [1] Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC).
    Liu, Stephen, V
    Vanderwalde, Ari M.
    Mamdani, Hirva
    Raez, Luis E.
    Baca, Yasmine
    Xiu, Joanne
    Korn, Wolfgang Michael
    Nagasaka, Misako
    Pai, Sachin Gopalkrishna
    Socinski, Mark A.
    Nieva, Jorge J.
    Kim, Chul
    Wozniak, Antoinette J.
    Ikpeazu, Chukwuemeka
    Lopes, Gilberto
    Spira, Alexander, I
    Judd, Julia
    Kim, Edward S.
    Borghaei, Hossein
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] Prognostic significance and origin of plasma KRAS mutations in patients with non-small cell lung cancer (NSCLC)
    Gautschi, Oliver
    Ziegler, Annemarie
    Huegli, Barbara
    Gugger, Mathias
    Ratschiller, Daniel
    Mack, Philip C.
    Kung, Hsing-Jien
    Stahel, Rolf A.
    Gandara, David R.
    Betticher, Daniel C.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S443 - S443
  • [3] Exploring the association between KRAS mutations and depression in non-small cell lung cancer (NSCLC) patients
    Li, Jenny Jing
    Harper, Jessica
    Bhulani, Nizar
    Gerber, David E.
    Khan, Saad A.
    Madrigales, Alejandra
    Gates, Samantha
    Toups, Marisa
    Beg, Muhammad Shaalan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (31)
  • [4] KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients
    Garzon, Monica
    Villatoro, Sergi
    Teixido, Cristina
    Mayo, Clara
    Martinez, Alejandro
    Llanos Gil, Maria de Los
    Viteri, Santiago
    Morales-Espinosa, Daniela
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (05) : 511 - 516
  • [5] Frequency ofEGFR and KRAS Mutations in Non-Small Cell Lung Cancer (NSCLC) in a Brazilian Population and Correlation with Genetic Ancestry Markers
    Dias, C.
    Scapulatempo, C.
    Viana, L.
    Miziara, J.
    Pereira, R.
    Reis, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 904 - 904
  • [6] Efficacy of current immunotherapies in patients (pt) with metastatic non-small cell lung cancer (NSCLC) harboring KRAS mutations
    Rincon, L. Notario
    Pous, A.
    Paradis, A. Lopez
    Notario, A.
    Salamero, M. Cucurull
    Gonzalez, A. Hernandez
    Vinolas, M. Domenech
    Costa, E. Carcereny
    Bueno, M. T. Moran
    Munoz, A.
    Mate, J. L.
    Sanz, C.
    Morgui, M. Saigi
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1066 - S1067
  • [7] A RANDOMIZED DISCONTINUATION PHASE II TRIAL OF RIDAFOROLIMUS IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH KRAS MUTATIONS
    Riely, Gregory J.
    Brahmer, Julie
    Planchard, David
    Crino, Lucio
    Doebele, Robert C.
    Maz Lopez, Luis
    Gettinger, Scott N.
    Schumann, Christian
    Guan, Shanghong
    Atkins, B.
    Ebbinghaus, S.
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S608 - S609
  • [8] PREDICTIVE VALUE OF KRAS AND BRAF MUTATIONS IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH CHEMOTHERAPY
    Dingemans, Anne-Marie
    Smit, Egbert F.
    Heideman, Danielle
    Mellema, Wouter
    Derks, Jules
    Van, Robertjan Suylen
    Thunnissen, Erik
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1044 - S1044
  • [9] Predictive and prognostic value of KRAS mutations in advanced non-small cell lung cancer (NSCLC) patients treated with chemotherapy
    Mellema, Wouter W.
    Dingemans, Anne-Marie C.
    Smit, Egbert F.
    Derks, Jules
    Heideman, Danielle A. M.
    van Suylen, Robertjan
    Thunnissen, Frederik B.
    CLINICAL CANCER RESEARCH, 2012, 18 (03)
  • [10] Multiplicity of EGFR and KRAS Mutations in Non-small Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors
    Benesova, Lucie
    Minarik, Marek
    Jancarikova, Dana
    Belsanova, Barbora
    Pesek, Milos
    ANTICANCER RESEARCH, 2010, 30 (05) : 1667 - 1671